SUMMARY ANSWER: FSH actively promotes P synthesis and output from granulosa cells without luteinization by up-regulating the expression and increasing enzymatic activity of 3β-hydroxysteriod dehydrogenoase (3β-HSD), which converts pregnenolone to P.
STUDY DESIGN, SIZE, DURATION: A translational research study.
PARTICIPANTS/MATERIALS, SETTING, METHODS:
Human ovarian cortical samples (n = 15) and non-luteinizing FSH-responsive human mitotic granulosa cell line (HGrC1) were stimulated with rec-FSH at 12.5, 25 and 50 mIU/ml concentrations for 24 and 48 h. FSH receptor expression was knocked-down and up-regulated in the granulosa cells using short hairpin RNA (shRNA) technology and activin-A administration, respectively. The expressions of the steroidogenic enzymes were analyzed at mRNA level by real-time quantitative RT-PCR, and protein level by western blot and immunoprecipitation assay. The enzymatic activity of 3β-HSD was measured using a spectrophotometric method. In vitro estradiol (E 2 ) and P productions of the cells before and after FSH stimulation were measured by electrochemiluminescence immunoassay method.
MAIN RESULTS AND THE ROLE OF CHANCE:
Stimulation of the HGrC1 cells with FSH resulted in a dose-dependent increase in the mRNA and protein level of 3β-HSD. Overall, when all time points and FSH doses were analyzed collectively, FSH significantly up-regulated the mRNA expression of its own receptor (3.73 ± 0.06-fold, P < 0.001), steroidogenic acute regulatory protein (stAR, 1.7 ± 0.03-fold, P < 0.01), side-chain cleavage enzyme (SCC, 1.75 ± 0.03-fold, P < 0.01), aromatase (4.49 ± 0.08-fold, P < 0.001), 3β-HSD (1.68 ± 0.02-fold, P < 0.01) and 17β-hydroxy steroid dehydrogenase (17β-HSD, 2.16 ± 0.02-fold, P < 0.01) in the granulosa cells. Expression of 17α-hydroxylase (17α-OH, 1.03 ± 0.01-fold P > 0.05) did not significantly change. Similar changes were observed in the protein expression analysis of these enzymes on western blotting after FSH stimulation. FSH significantly increased 3β-HSD, 17β-HSD and aromatase in a dose-dependent manner but did not affect 17α-OH. Protein expression of P was increased along with 3β-HSD after FSH stimulation, which was further evidenced by immunoprecipitation assay. Enzymatic activity of 3β-HSD was significantly enhanced by FSH administration in the HGrC1 cells in a dose-dependent manner. In line with these findings P output (1.05 ± 0.3 vs. 0.2 ± 0.1 ng/ml, respectively, P < 0.001) from the samples stimulated with FSH were significantly increased along with E 2 (1918 ± 203 vs. 932 ± 102 pg/ml, respectively, P < 0.001) compared to unstimulated controls. FSH-induced increase in 3β-HSD expression was amplified and reversed in the HGrC1 cells when FSH receptor expression was up-regulated by activin-A and down-regulated with shRNA, respectively.
Introduction
In the modern era of assisted reproductive technologies pituitary suppression with GnRH analogs has drastically reduced the incidence of premature LH surge to <2% per stimulated IVF cycle (Felberbaum and Diedrich, 1999) . Nevertheless, subtle elevations in serum progesterone (P) level during late follicular phase may still occur without LH surge in up to 35% and 38% of the stimulated IVF cycles with GnRH agonist and antagonist protocols, respectively, (Ubaldi et al., 1996a,b; Bosch et al., 2003; Venetis et al., 2013) . The premature rise in serum P before ovulation trigger may reduce the success of pregnancy in stimulated IVF cycles by advancing endometrial histology and impairing its receptivity when fresh embryo transfer (ET) is performed (Urman et al., 1999; Labarta et al., 2011; Venetis et al., 2013; Hill et al., 2015; Venetis et al., 2015) . It is well-documented that serum P level at the time of hCG administration is significantly correlated with the magnitude of ovarian response to stimulation (antral follicle count ≥14 mm, estradiol (E 2 ) level at the time of hCG administration and the number of eggs retrieved) (Urman et al., 1999; Kyrou et al., 2012; Ochsenkuhn et al., 2012; Griesinger et al., 2013; Venetis et al., 2013; Venetis et al., 2015; Martinez et al., 2016) . Even though the underlying mechanism of this event is obscure its almost exclusive occurrence in stimulated but not in natural IVF cycles raises a fundamental question as to whether FSH stimulation itself might be responsible for P output from granulosa cells without luteinization. To address this issue, we designed an experimental study and investigated (i) whether FSH stimulates granulosa cell P output by up-regulating the expression of 3β-hydroxysteriod dehydrogenoase (3β-HSD); the enzyme that converts pregnenolone to P and (ii) whether FSH induces proportional increases in the expression of ovarian steroidogenic enzymes (steroidogenic acute regulatory protein (stAR), side-chain cleavage enzyme (SCC), 3β-HSD, 17α-hydroxylase (17α-OH), 17β-hydroxy steroid dehydrogenase (17β-HSD) and aromatase). To this end, human ovarian tissue samples and non-luteinizing, mitotic and FSH-responsive human granulosa cells (HGrC1) were stimulated with rec-FSH at different concentrations and time points. To mimic the ovarian micro-environment in the ovary in stimulated IVF cycles, FSH was used at concentrations corresponding to its endogenous levels in the sera of IVF patients undergoing ovarian stimulation with rec-FSH (Devroey et al., 2009; Fauser et al., 2010; McCulloh et al., 2012) . FSH-induced changes in the enzymatic activity of 3β-HSD was measured, and the expression of the ovarian steroidogenic enzymes were analyzed by quantitative real-time PCR and western blot. FSH responsiveness of these enzymes was further investigated after FSH receptor was up-regulated with activin-A, and downregulated with short hairpin RNA (shRNA) technology.
Material and Methods

FSH-responsive mitotic non-luteinizing human granulosa cells
HGrC1 cells are kindly provided by Dr A. Iwase (Nagoya University, Japan). This cell line is a human non-luteinized granulosa cell line expressing enzymes related to steroidogenesis, such as stAR, aromatase and FSH receptor. They produce estrogen in response to FSH stimulation but do not possess LH receptor and are not capable of undergoing luteinization, similar to the growth characteristics of mitotic granulosa cells of growing preantral/early antral follicles (Bayasula et al., 2012) . The cells were cultured in 10 cm culture plates at the density of 1 × 10 6 cells/plate.
Ethical approval
The study was approved the institutional review board of Koc University (2015.204.IRB2.074) . Informed consent was obtained from the patients who undergoing laparoscopic excision of ovarian cysts.
Ovarian tissue samples
The ovarian cortical tissue samples were obtained from patients who underwent laparoscopic excision of dermoid cysts (n = 12) or endometriomas (n = 3) during the early follicular phase of the menstrual cycle. Healthy intact cortical tissue pieces embedded within the cyst and removed with it were used for the assays. The samples were minced into equal sizes of 0.5 × 0.5 cm and cultured in 24-well plates using 1 ml of DMEM-F12 culture media supplemented with 10% fetal bovine serum (FBS) and FSH at 12.5, 25 and 50 mIU/ml concentrations. Half of the culture media was replenished every day and stored at −80°C until assayed for their in vitro E 2 and P productions. After 48 h culture period, the samples were halved. One half was used to prepare tissue lysates for protein expression analysis of steroidogenic enzymes and P by western blot. The other half was fixed, paraffin-embedded and serially sectioned (5 microns apart) and examined histologically to rule out any premature luteinization and the presence of a remnant corpus luteum from the previous cycle. Differential follicle counts are expressed as the number of primordials and growing multilayer follicles/mm 2 .
Western blotting
Mouse anti-human monoclonal antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz Biotechnology, Inc., TX, USA) for the detection of human 3β-HSD Type II (sc-100466), 17β-HSD type-I (sc-376719) and 17α-OH (CYP17A1, sc-376711). Mouse monoclonal antibody against human P was purchased from LifeSpan BioSciences (Seattle, WA, USA, LS-C194163). Aromatase (CYP19A, ab34193) monoclonal mouse antibody was from Abcam (Abcam Inc., MA, USA). Antivinculin antibody (Sigma-Aldrich, St. Louis, MO, USA) was used as loading control at a dilution of 1:10 000. Cell lysates for western blot were prepared using radioimmunoprecipitation assay buffer (Sigma-Aldrich). Membranes were incubated overnight at 4°C with the antibodies at the concentrations recommended by the manufacturers. Goat anti-mouse IgG-horse-radish peroxidase was used as secondary antibody at a dilution of 1:2000 (Santa Cruz; sc-2005) . The experiments were done in triplicate.
Immunoprecipitation assay
Cells were harvested under non-denaturating conditions, lysed on ice and centrifuged at 14 000g for 20 min at 4°C. About, 20 µl of cell lysates were analyzed as a loading control by western blotting using 1:10 000 dilution of anti-vinculin antibody (Sigma-Aldrich). Remaining 200 µl of cell lysates were incubated either with anti-progesterone antibody (LifeSpan, #LS-C194163) or anti-3BHSD antibody (Santa Cruz, #sc-100466) with a dilution of 1:50 with gentle rocking overnight at 4°C. Then, 10 µl Protein-G agarose beads (Cell Signaling, #37478) were added to pull down antigenprimary antibody conjugate and incubated with gentle rocking for 3 h at 4°C. After washing three times with 500 µl of 1× cell lysis buffer, pellets were resuspended with 15 μl 4× sodium dodecyl sulfate sample buffer and analyzed by western blotting.
3β-HSD enzyme assay protocol 3β-HSD catalyzes the conversion of pregnenolone into P in the presence of nicotinamide adenine dinucleotide (NAD). As a result of this enzymatic activity NADH is also produced along with P. HGrC1 cells were seeded into 100 mm plates at the density of 1 × 10 6 cells/well and treated with FSH 25 and 50 mIU/ml for 24 and 48 h. About, 1600 µl of 0.15 M Tris-HCl was used to collect cells from the plates with the help of a scraper. Cells were centrifuged at 12 000g for 10 min at 4°C to remove the pellet. For enzyme activity assay 0.75 ml 0.15 M Tris-HCl, 0.75 ml 400 µM NAD and 0.1 ml 400 µM Pregnenolone mix were prepared for each tube. About, 200 µl of cell homogenate, containing the enzyme, was added to each tube. Tubes were incubated at 37°C for 45 min. At the end of the incubation period, 500 µl color reagent was added into the tubes and after color formation 2 ml phthalate buffer was added to end the reaction. Color reagent was prepared by dissolving 50 mg nitroblue tetrazolium, 15 mg phenazine methosulfate in 50 ml distilled water with the addition of 1 ml Tween 20. Phthalate buffer was prepared with 3.57 g potassium hydrogen phthalate in 50 ml 0.15 M HCl and 3 ml Tween 20. pH was adjusted to 4.25 and volume was completed to 300 ml with distilled water. Absorbance was read at 520 nm with plate reader.
Quantitative real-time PCR analysis
RNA isolation was performed with Quick-RNA MicroPrep Kit (Zymo Research, Irvine, CA, USA) according to the manufacturer's instructions. RNA was quantified with spectrophotometric read at 260 nm by Nanodrop 2000 (Thermo Fisher Scientific, MA, USA) and 1000 ng cDNA was prepared by using M-MLV Reverse Transcriptase (Invitrogen). Quantitative real-time expressions of mRNAs were detected and compared by using Light Cycler 480 SYBR Green I Master (Roche, Germany). The primers of the genes used in the study are in the Table I . RT-PCR experiments were repeated four times. For each experiment, three different readouts were obtained. So, for each steroidogenic enzyme, there were a total of 12 different values of mRNA expressions for quantitative analysis.
Hormone assays E 2 and P levels in the culture media were determined by using electrochemiluminescence immunoassay (ECLIA) (Elecsys and Cobas eimmunoassay analyzers, Roche Diagnostics, USA). Lower detection limits of E 2 and P were 5.00 pg/ml (18.4 pmol/ml) and 0.030 ng/ml (0.095 nmol/ml), respectively.
cAMP-Glo assay
The cAMP-Glo assay (Promega, WI, USA) is a bioluminescent assay that is used to measure cellular cAMP levels. Intercellular cAMP activity is regulated when the test compound stimulates G protein-coupled receptors (GPCRs). Increased cAMP stimulates protein kinase A phosphorylation by ATP. The cAMP-Glo assay measures the remaining ATP level by combining it with luciferin in the presence of oxygen and the effects of the test compound on the cells can be determined by luminescence output. FSH was used as the test compound in the HGrC1 cells.
shRNA transfection FSHR was knocked-down in HGrC1 cells by using FSHR shRNA Plasmid by Santa Cruz (sc-35415-SH) according to the instructions of the company. Cells were prepared in six-well tissue culture plates and manufacturer's protocol was followed during transfection. Control transfection was performed by using Control shRNA Plasmid-A by Santa Cruz 
Statistical analysis
mRNA and protein levels of the steroidogenic enzymes and hormone levels (E 2 and P) are continuous variables, expressed as the mean ± SD. ANOVA and Bonferroni multiple comparison post hoc test were applied to compare the groups. Significance level was set at 5% (P < 0.05). SPSS statistical program (version 22) was used to analyze the data.
Results
The schematic illustration of the experimental methodologies used in the study is depicted in the Supplementary Fig. S1 . In brief, the effect of FSH stimulation on the expression of steroidogenic enzymes was analyzed at mRNA and protein levels by quantitative real-time PCR analysis (qRT-PCR) and western blot, respectively. FSH driven changes in the enzymatic activity of 3β-HSD was determined by measuring the conversion of pregnenolone to P by spectrophotometric method. Steroidogenic activity of the samples was analyzed by measuring their E 2 and P productions in vitro.
FSH receptor expression and cAMP-Glo assays
The presence of FSH receptor and its responsiveness to exogenously administered FSH were validated in the samples using qRT-PCR and cAMP-Glo assays, respectively. Treatment of the HGrC1 cells with FSH at 12.5, 25 and 50 mIU/ml concentrations resulted in a robust increase in the intracellular cAMP level 10 min after stimulation from a baseline level of 2.2 nM to 4.9, 7.9 and 14.1 nM, respectively. Similarly, FSH receptor expression increased 2.5, 3.7 and 4.1-fold, respectively at 24 h after stimulation with FSH at the same concentrations, confirming FSH responsiveness of these cells ( Supplementary Fig. S2 ).
Analysis of FSH-induced transcriptional changes in the expressions of 3β-HSD and other steroidogenic enzymes in the HGrC1 cells FSH stimulation caused a dose-dependent increase in the expression of 3β-HSD in the HGrC1 cells (Fig. 1) . The increase was much more evident at 48 h (1.78, 2.1 and 2.6-fold, respectively) compared to the levels at 24 h (1.18, 1.21 and 1.24-fold over basal levels, respectively) after stimulation with FSH at 12.5, 25 and 50 mIU/ml concentrations. The expressions of the other steroidogenic enzymes were also increased after FSH stimulation in a dose-dependent manner with the most robust increase observed in the aromatase expression. 17α-OH was one notable exception as its expression did not change significantly after FSH stimulation. Overall, when all time points and FSH doses were analyzed collectively, FSH significantly increased the expression of its own receptor (3.73-fold, P < 0.001), stAR (1.7-fold, P < 0.01), SCC (1.75-fold, P < 0.01), aromatase (4.49-fold, P < 0.001), 3β-HSD (1.68-fold, P < 0.01) 17β-HSD (2.16-fold, P < 0.01) except for 17α-OH (1.03-fold P > 0.05).
Analysis of FSH-induced translational changes in the expression of 3β-HSD and other steroidogenic enzymes in the granulosa cells
The protein expression of the steroidogenic enzymes in the HGrC1 cells at baseline and 24 and 48 h after stimulation with FSH at 12.5, 25 and 50 mIU/ml concentrations are shown as a western blot image in Fig. 2A . FSH stimulation did not cause any notable changes in the expression of 3β-HSD and P at 24 h after stimulation. However, with continued stimulation both 3β-HSD and P markedly increased at 48 h in a dose-dependent manner. FSH also increased the expression of aromatase and 17β-HSD. By contrast, 17α-OH level was almost undetectable and did not respond to FSH stimulation. These findings were further evidenced by immunoprecipitation assay, in which antigen-primary antibody complexes (3β-HSD and P bounded by their specific antibodies) were pulled down first and then analyzed by western blotting (Fig. 2B) . To see if increased expression of P in western blot is associated with increased production and output of P from the HGrC1 cells, in vitro E 2 and P productions of the same population of the cells were measured ECLIA in the spent culture media. Twenty-four hours after FSH stimulation there was discordance between E 2 and P production of the cells. FSH caused a dose-dependent increase in E 2 production but did not cause any notable increase in the P production at 24 h of stimulation. At 48 h, P level began to rise along with E 2 and mitotic expansion of the granulosa cells in response to FSH stimulation in a concentrationdependent manner (Fig. 2C and D) .
Activin-A has mitogenic effects on the granulosa cells and increases follicle growth under both in vivo and in vitro conditions. It also up-regulates the expression of aromatase and FSH receptor, and the response of the granulosa cells to FSH stimulation (Smitz et al., 1998; Oktem and Oktay, 2007; Telfer et al., 2008; Oktem and Urman, 2010) . Thus, in another set of experiments the HGrC1 cells were stimulated with recombinant activin-A (60 ng/ml) alone or with FSH (25 mIU/ml) for 48 h to analyze how activin-A induced increase in FSH responsiveness of the cells changes the expression of 3β-HSD, P and other steroidogenic enzymes. The expression of FSH-R (4-fold), 3β-HSD (2.1-fold), 17β-HSD (2-fold) and aromatase (4-fold) but not 17α-OH (1.1-fold) were significantly increased in the cells stimulated with FSH in comparison to control cells. Activin-A treatment alone markedly up-regulated FSH-R (2-fold), 17β-HSD (1.3-fold) and aromatase (3.2-fold) but did not cause any significant change in the expression of 3β-HSD (1.1-fold) and 17α-OH (1.01-fold) when compared to control cells. The expression of FSH-R (8 vs. 4-fold, respectively), 3β-HSD (3.3 vs. 2.1-fold, respectively), 17β-HSD (3.2 vs. 2-fold, respectively) and aromatase (8 vs. 4-fold, respectively) were further increased in the cells stimulated with FSH + Activin-A vs. FSH. The expression of 17α-OH did not change significantly (1.23 vs. 1.12-fold, respectively) between the cells stimulated with FSH + Activin-A vs. FSH (Fig. 3A) . The expression of 3β-HSD (2.7 ± 0.04 vs. 1.2 ± 0.02, P < 0.01) and P (2.82 ± 0.04 vs. 1.3 ± 0.03, P < 0.01) were further increased in the HGrC1 cells on western blot when they were stimulated with FSH + activin-A combination compared to those stimulated with FSH alone (Fig. 3B) .
Analysis of FSH-induced changes in 3β-HSD and other steroidogenic enzymes in ovarian cortical tissue samples
In vitro stimulation of ovarian tissue samples with FSH at 12.5, 25 and 50 mIU/ml concentrations resulted in a dose-dependent increase in the expression of 3β-HSD, P, aromatase and 17β-HSD whereas such an increase was not observed in 17α-OH expression (Fig. 4A) . Quantification of the intensity of the signals revealed that FSH stimulation significantly increased the expression of 3β-HSD (1.6-fold, P < 0.01), 17β-HSD (1.9-fold, P < 0.01) and aromatase (3.2-fold, P < 0.001) but not 17α-OH (1.12-fold, P > 0.05) compared to controls (Fig. 4B) . When in vitro hormone productions of these samples were measured by ECLIA, it appeared that P output from FSH stimulated samples was increased at 48 h along with E 2 in a dose-dependent fashion (Fig. 4C) . At the end of 48 h culture period differential follicle counts were calculated in the same samples. While the mean number of primordial follicles did not differ among the groups, those samples stimulated with 25 (0.82 ± 0.2 vs. 0.67 ± 0.2, respectively, P < 0.05) and 50 mIU/ml FSH (0.98 ± 0.2 vs. 0.67 ± 0.2, respectively, P < 0.01) harbored significantly higher number of secondary follicles compared to control samples Fig. 4D .
FSH receptor knock-down experiment
We knocked-down the FSH receptor gene in the HGrC1 cells using shRNA technology to analyze the changes in the expression of steroidogenic enzymes. The mRNA level of FSH significantly decreased and cAMP production of the cells in response to FSH (25 mIU/ml) stimulation was significantly blunted, confirming that FSH-R expression was adequately silenced. Analysis of the expression of steroidogenic enzymes in these cells revealed that knocking down the FSH receptor is associated with a significant reduction in the expression of 3β-HSD, 17β-HSD and aromatase. However, the expression of 17α-OH did not decrease considerably after FSH receptor was knocked-down ( Fig. 5A and B) . ern blot and immunoprecipitation methods, and the measurement of in vitro P and E 2 productions of the cells by electro-chemiluminescence immunoassay (ECLIA) method before and after stimulation with different concentrations of FSH. FSH stimulation caused a dose-dependent increase in the expressions of 3β-HSD and P in a dose-dependent manner particularly at 48 h after FSH treatment (A). FSH also stimulated 17β-hydroxy steroid dehydrogenase (17β-HSD) and aromatase expression at both 24 and 48 h but did not cause a notable change in the 17α-OH expression. Immunoprecipitation assay that employs western blotting after pulling down 3β-HSD and P using their specific antibodies confirmed dose-dependent increase in the expression of 3β-HSD and P in the HGrC1 cells after FSH stimulation (B). In line with these findings in vitro E 2 production of the cells rapidly rose without a notable change in P production at 24 h. With continued FSH stimulation P level began to rise at 48 h in a dose-dependent manner along with E 2 (C) and mitotic expansion of the HGrC1 cells (D). P, progesterone; E 2 , estradiol. Figure 3 Expression of 3β-HSD and P are further increased in the HGrC1 cells after treatment with FSH and activin-A. FSH stimulation significantly enhanced the expression of its own receptor FSH-R, 3β-HSD, 17β-HSD and aromatase but not 17α-OH in comparison to control cells. Activin-A treatment alone markedly up-regulated FSH-R, 17β-HSD and aromatase (3.2-fold) but did not cause any significant change in the expression of 3β-HSD and 17α-OH when compared to control cells. The expression of FSH-R, 3β-HSD, 17β-HSD and aromatase were further increased in the cells stimulated with FSH + Activin-A vs. FSH only. However, 17α-OH did not change significantly after FSH + Activin-A compared to those stimulated with FSH only (A). The expression of 3β-HSD and P on western blot were further increased in the HGrC1 cells when they were stimulated with FSH + activin-A combination compared to those stimulated with FSH alone (B).
FSH driven changes in the enzymatic activity of 3β-HSD
Stimulation of the HGrC1 cells with FSH at 12.5, 25 and 50 mIU/ml concentrations significantly increased enzymatic activity of 3β-HSD at 48 h. As a result of this, the conversion of the substrate pregnenolone to P was significantly increased along with the generation of NADH as another indicator of the presence of enzymatic activity of 3β-HSD.
This stimulatory effect of FSH on the 3β-HSD activity was dosedependent (Fig. 5C) .
Discussion
Serum P level may prematurely rise before ovulation trigger and reduce pregnancy rates by impairing endometrial receptivity in stimulated IVF Figure 4 (A) Analysis of FSH-induced changes in the expression of steroidogenic enzymes and P in the ovarian tissue samples. Stimulation of ovarian tissue samples with FSH for 48 h significantly up-regulated the protein expression of 3β-HSD (1.6-fold, P < 0.01) and P in a dose-dependent fashion in addition to its stimulatory effect on the 17β-HSD (1.9-fold, P < 0.01) and aromatase expression (3.2-fold, P < 0.001). 17α-OH expression (1.12-fold, P > 0.05) did not significantly change after FSH stimulation. (B) Proposed mechanism of how FSH stimulation promotes P output from HGrC1 cells. According to the two-cell two gonadotropins theory P produced by granulosa cells enter theca cells to be converted into androgens because CYP17A1 enyzmes (cytochrome P450 enzymes; 17α-OH and 17, 20 lyase) are not responsive to FSH, therefore no further reactions take place downstream in the granulosa cells. When this effect is combined with direct stimulatory effect of FSH on 3β-HSD and P biosynthesis, accumulated P may leak into systemic circulation. stAR: Steroidogenic acute regulatory protein; CYP11A1: SCC; CYP17A1 (17α-OH and 17,20 lyase), 17β-HSD; 3β-HSD. (C) In vitro E 2 and P production of the samples stimulated with FSH. In vitro stimulation of ovarian tissue samples with FSH resulted in a dose-dependent increase in P output along with E 2 . This effect of FSH became evident at 48 h of stimulation. (D) Differential follicle counts in the ovarian tissue samples stimulated with and without FSH. The number of primordial follicles was comparable across the groups. Secondary follicles >200 microns were found at significantly higher numbers in the samples treated with FSH at 25 and 50 mIU/ml concentrations compared to control samples.
cycles culminating in a fresh ET (Venetis et al., 2013) . Since the rise in P precedes hCG administration and is not associated with premature LH surge it does not reflect a true luteinization event. It is typically seen in stimulated IVF cycles and is significantly correlated with the intensity of ovarian stimulation; hence patients with more follicles and oocytes have higher P levels (Urman et al., 1999; Kyrou et al., 2012; Ochsenkuhn et al., 2012; Griesinger et al., 2013; Venetis et al., 2013; Venetis et al., 2015; Martinez et al., 2016) . These findings suggest that gonadotropin stimulation and/or the degree of ovarian stimulation might play a pivotal role in premature rise of serum P level before ovulation trigger at the late follicular phase during multi-follicular development in stimulated IVF cycles. We have shown in this study that FSH stimulates 3β-HSD expression and P biosynthesis in human granulosa cells and ovarian tissue samples in addition to its stimulatory effect on the expression of other steroidogenic enzymes required for estrogen synthesis. FSH had a direct stimulatory effect on the enzymatic activity of 3β-HSD and increased the conversion of pregnenolone to P in the HGrC1 cells. As a result of this, P output from the samples stimulated with FSH was increased along with E 2 in a dose-dependent fashion. This effect of FSH was amplified and reversed when FSH receptor expression was upregulated by activin-A, and down-regulated with shRNA, respectively. Taken together these results provide molecular evidence in the human for a direct stimulatory action of FSH on P production from human granulosa cells via upregulation of 3β-HSD expression and increasing its enzymatic activity. To the best of our knowledge, this is the first study that shows a direct stimulatory effect of FSH on the expression and enzymatic activity of 3β-HSD, and P synthesis in human granulosa cells.
As another important finding, we also showed in this study that the expression of 17α-OH did not increase after FSH stimulation in HGrC1 cells and ovarian tissue samples. These results support the findings of the previous studies on ovarian steroidogenesis and the two-cell-two-gonadotropin theory in human (Ryan and Petro, 1966; McNatty et al., 1979; Voutilainen et al., 1986) . According to this theory, in order to be converted into androgens, pregnenolone and P produced by granulosa cells must enter the theca cells where they undergo 17 hydroxylation and side-chain splitting reactions by the Analysis of the expression profiles of the steroidogenic enzymes in these cells revealed that knocking down FSH receptor is associated with a significant reduction in the expression of SCC (decreased by 84%), stAR (78%), 3β-HSD (80%), 17β-HSD (77%) and aromatase (87%). However, a similar degree of reduction was not observed in the expression of 17α-OH (47%) after FSH receptor was knocked-down (B). (C) Enzymatic activity assay of 3β-HSD. FSH stimulation significantly increased the enzymatic activity of 3β-HSD, which is indicated by increased production of NADH and the conversion of pregnenolone to P in the HGrC1 cells. The stimulatory effect of FSH on the enzymatic activity of 3β-HSD is particularly evident at 48 h after stimulation.
actions of the enzymes 17α-OH and 17,20 lyase, respectively. These reactions are mainly driven by the actions of LH (Hillier et al., 1994) . 17α-OH and 17,20 lyase are encoded by the same gene CYP17A1. Therefore, the weak baseline expression of 17α-OH and its unresponsiveness to FSH stimulation as shown by us and other previous studies not only help suppress androgen synthesis in the granulosa cells but also provide a biological basis for two-cell two gonadotropins theory (Voutilainen et al., 1986) . What represses 17α-OH in the granulosa cells remained unknown until 2009 when a study revealed that the AP-1 transcription factor, c-fos, was responsible for 17α-OH repression and hence suppression of androgen production in human granulosa cells (Patel et al., 2009) . By contrast, the activity of 17α-OH is already high in the rat granulosa and cannot be further amplified by FSH or LH (Johnson et al., 1981; Johnson and Griswold, 1983) , indicating that granulosa cells can produce estrogen from P and do not require androgen precursors from the theca and/or interstitium. It therefore does not support the two-cell-two-gonadotropin theory at least in the rats. FSH stimulates 3β-HSD activity and promotes P synthesis in a dosedependent manner in cultured rat granulosa cells Fanjul et al., 1984) . Concomitant treatment with GnRH decreased the FSH stimulation of enzyme activity (Jones and Hsueh, 1981) . A similar synergistic effect on P synthesis was observed when the cells were treated with FSH and epidermal growth factor ; and FSH and E 2 combinations (Welsh et al., 1983) . Therefore, the stimulatory action of FSH on 3β-HSD activity and P synthesis in the rat granulosa cells is to provide precursors for direct estrogen synthesis without the use of androgens. In the primate model FSH treatment of granulosa cells isolated from immature follicles stimulated both P production and aromatase activity (Miro and Hillier, 1992) . But these studies received little or no clinical attentions since clinical implications of FSH-induced P elevations were not recognized at that time.
Unresponsiveness of 17α-OH to FSH stimulation in human granulosa cells not only supports the two-cell theory of human ovarian estrogen synthesis but may also provide a plausible explanation why FSH stimulation promotes P output from granulosa cells without luteinization. In the absence of LH support the activity of 17α-OH cannot be enhanced with FSH stimulation only. This may delay the conversion of P into androgens in theca cells leading to their accumulation and leak into systemic circulation. When this effect is combined with direct stimulatory effect of FSH on 3β-HSD and P biosynthesis, high input precursor steroids generated during multi-follicular development under the influence of tonically elevated FSH level in stimulated IVF cycles may exceed the ability of the ovary to effectively convert them into estrogen pathway, creating a relative shunting at 17 hydroxylation step that diverts these precursors into P pathway for conversion to androgenic substrates for final estrogen synthesis.
Conclusion
This study shows that FSH has a direct stimulatory effect on 3β-HSD and P production in human granulosa cells, providing a molecular explanation why serum P level is elevated prior to ovulation trigger in stimulated IVF cycles. Given its relevance to the clinical practice in assisted reproduction technologies and direct impact on the pregnancy rates this issue deserves more attention at molecular level.
